Wound telehealth program established globally for VA Medical Centres
New Zealand-based ARANZ Medical's Silhouette wound telehealth program will be established as a VA national platform by the US Department of Veteran's Affairs. The new agreement with distribution partner Iron Bow Technologies, LLC, will include a national server and new hardware and software upgrades. This global solution will assist patients and providers by reducing cost of care, waiting times and improve patient experience. Veterans with wounds will have access to significantly improved care. | https://www.biospectrumasia.com/news/53/17667/nz-unveils-national-platform-for-wound-telehealth-assessments.html
Researchers at The University of Queensland will progress toward a trial to see if a specialised dietary fibre supplement is safe for use in children with type 1 diabetes after positive results in adults. With the increase of type I diabetes in the last 50 years, growing evidence is showing that changes in gut bacteria may hold a secret to the triggering of the disease. By targeting the gut microbiome with specialised dietary fibre supplements, researchers hope to see a low-cost approach to prevention and glucose management. | https://medicine.uq.edu.au/article/2021/07/diabetes-research-challenging-paramount
Researchers at the University of Queensland and WEHI have identified a new generation anti-cancer drug that could be repurposed for aggressive childhood brain tumour, medulloblastoma. The international collaboration spent five years mapping the genetics of this common and fatal brain cancer for children. The existing drug has been approved for other diseases or cancers but never tested in paediatric brain tumours. Ixabepilone which is used to treat breast cancer, was found to block tumour growth and significantly extend survival rates in preclinical models. | https://www.uq.edu.au/news/node/129501
Lynn Wood
Madeline Cunningham
